IndraLab
Statements
reach
"Additionally, the CaM1 assay showed that compared with the control treatment, treatment with the LC , LC , and LC doses of scoparone for 48 h markedly increased the specific activation of PDE by extracted CaM in vivo (by 3.67-, 2.79-, and 1.87-fold, respectively), further demonstrating that scoparone is an agonist of CaM1 (Fig. 4d)."